These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30810703)

  • 1. Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial.
    Reardon MJ; Feldman TE; Meduri CU; Makkar RR; O'Hair D; Linke A; Kereiakes DJ; Waksman R; Babliaros V; Stoler RC; Mishkel GJ; Rizik DG; Iyer VS; Gleason TG; Tchétché D; Rovin JD; Lhermusier T; Carrié D; Hodson RW; Allocco DJ; Meredith IT;
    JAMA Cardiol; 2019 Mar; 4(3):223-229. PubMed ID: 30810703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial.
    Rizik DG; Rajagopal V; Makkar RR; Bajwa T; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Iyer VS; Buchbinder M; Götberg M; Bjursten H; Allocco DJ; Reardon MJ
    JAMA Netw Open; 2022 Oct; 5(10):e2238792. PubMed ID: 36301543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial.
    Asch FM; Vannan MA; Singh S; Khandheria B; Little SH; Allocco DJ; Meredith IT; Feldman TE; Reardon MJ; Weissman NJ
    Circulation; 2018 Jun; 137(24):2557-2567. PubMed ID: 29530883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
    Feldman TE; Reardon MJ; Rajagopal V; Makkar RR; Bajwa TK; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Rizik DG; Iyer VS; Gleason TG; Tchétché D; Rovin JD; Buchbinder M; Meredith IT; Götberg M; Bjursten H; Meduri C; Salinger MH; Allocco DJ; Dawkins KD
    JAMA; 2018 Jan; 319(1):27-37. PubMed ID: 29297076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial.
    Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Hildick-Smith D; Cunnington M; Wolf A; Barbanti M; Tchetchè D; Garot P; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Deutsch O; Kempfert J; Søndergaard L; Butter C; Trillo-Nouche R; Lotfi S; Möllmann H; Joner M; Abdel-Wahab M; Bogaerts K; Hengstenberg C; Capodanno D
    Circulation; 2020 Dec; 142(25):2431-2442. PubMed ID: 33054367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
    Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.
    Bleiziffer S; Bosmans J; Brecker S; Gerckens U; Wenaweser P; Tamburino C; Linke A;
    Clin Res Cardiol; 2017 Oct; 106(10):784-795. PubMed ID: 28484830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Self-Expanding and Mechanically Expanded Transcatheter Aortic Valve Prostheses.
    Gooley RP; Talman AH; Cameron JD; Lockwood SM; Meredith IT
    JACC Cardiovasc Interv; 2015 Jun; 8(7):962-71. PubMed ID: 26088514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
    Van Mieghem NM; Deeb GM; Søndergaard L; Grube E; Windecker S; Gada H; Mumtaz M; Olsen PS; Heiser JC; Merhi W; Kleiman NS; Chetcuti SJ; Gleason TG; Lee JS; Cheng W; Makkar RR; Crestanello J; George B; George I; Kodali S; Yakubov SJ; Serruys PW; Lange R; Piazza N; Williams MR; Oh JK; Adams DH; Li S; Reardon MJ;
    JAMA Cardiol; 2022 Oct; 7(10):1000-1008. PubMed ID: 36001335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve.
    Tchétché D; Windecker S; Kasel AM; Schaefer U; Worthley S; Linke A; Abdel-Wahab M; Le Breton H; Søndergaard L; Spence MS; Petronio S; Baumgartner H; Hovorka T; Blanke P; Reichenspurner H
    JACC Cardiovasc Interv; 2019 Apr; 12(7):673-680. PubMed ID: 30947942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID).
    Alnasser S; Cheema AN; Simonato M; Barbanti M; Edwards J; Kornowski R; Horlick E; Wijeysundera HC; Testa L; Bedogni F; Amrane H; Walther T; Pelletier M; Latib A; Laborde JC; Hildick-Smith D; Kim WK; Tchetche D; Agrifoglio M; Sinning JM; van Boven AJ; Kefer J; Frerker C; van Mieghem NM; Linke A; Worthley S; Asgar A; Sgroi C; Aziz M; Danenberg HD; Labinaz M; Manoharan G; Cheung A; Webb JG; Dvir D;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28400461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial.
    Oh JK; Little SH; Abdelmoneim SS; Reardon MJ; Kleiman NS; Lin G; Bach D; Gillam L; Kar B; Coselli J; Sengupta PP; Grewal K; Chang J; Chang Y; Boulware M; Adams DH; Popma JJ;
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1364-1375. PubMed ID: 26508386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.